Skip to menu Skip to content Skip to footer

2024

Conference Publication

Detection of epigenetic priming in acinar cells after recovering from pancreatitis or metabolic stress

Wolff, Julia, Zhou, Quan, Schreiner, Nicole, Fahr, Lisa, Straub, Tobias, Mahajan, Ujjwal M., Holt, Eric, Bozdag, Beyza, Imhof, Axel, Mayerle, Julia, Halberg, Nils and Regel, Ivonne (2024). Detection of epigenetic priming in acinar cells after recovering from pancreatitis or metabolic stress. 56th European Pancreatic Club Meeting 2024, Santiago de Compostela, Spain, 26 - 29 June 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.pan.2024.05.309

Detection of epigenetic priming in acinar cells after recovering from pancreatitis or metabolic stress

2024

Conference Publication

Interplay of the proteotoxic CEL-MODY protein and oncogenic Kras in pancreatic cancer development

Fjeld, Karianne, Alam, Jahedul, López, Diego Iglesias, Kuznetsova, Ksenia, Seierstad, Renate V., Verbeke, Caroline, Vaudel, Marc, Regel, Ivonne, Halberg, Nils and Molven, Anders (2024). Interplay of the proteotoxic CEL-MODY protein and oncogenic Kras in pancreatic cancer development. 56th European Pancreatic Club Meeting 2024, Santiago de Compostela, Spain, 26 - 29 June 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.pan.2024.05.010

Interplay of the proteotoxic CEL-MODY protein and oncogenic Kras in pancreatic cancer development

2019

Conference Publication

Characterization of the anticancer and immunologic activity of RGX-019, a novel pre-clinical stage humanized monoclonal antibody targeting the MERTK receptor

Takeda, Shugaku, Andreu-Agullo, Celia, Sridhar, Subhasree, Halberg, Nils, Lorenz, Ivo C., Tavazoie, Sohail, Kurth, Isabel and Tavazoie, Masoud (2019). Characterization of the anticancer and immunologic activity of RGX-019, a novel pre-clinical stage humanized monoclonal antibody targeting the MERTK receptor. Annual Meeting of the American-Association-for-Cancer-Research (AACR), Atlanta Ga, Mar 29-Apr 03, 2019. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2019-LB-277

Characterization of the anticancer and immunologic activity of RGX-019, a novel pre-clinical stage humanized monoclonal antibody targeting the MERTK receptor

2013

Conference Publication

Hypertriglyceridemia Induced By Chronic Intermittent Hypoxia Is Mediated By Hypoxia Inducible Factor (hif-1)

Yao, Q., Drager, L. F., Shin, M. -K., Jun, J. C., Halberg, N., Scherer, P. E., Semenza, G. L. and Polotsky, V. Y. (2013). Hypertriglyceridemia Induced By Chronic Intermittent Hypoxia Is Mediated By Hypoxia Inducible Factor (hif-1). NEW YORK: AMER THORACIC SOC.

Hypertriglyceridemia Induced By Chronic Intermittent Hypoxia Is Mediated By Hypoxia Inducible Factor (hif-1)